EFG Asset Management North America Corp. Sells 1,312 Shares of Intuitive Surgical, Inc. $ISRG

EFG Asset Management North America Corp. lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.9% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 13,447 shares of the medical equipment provider’s stock after selling 1,312 shares during the period. Intuitive Surgical comprises 1.0% of EFG Asset Management North America Corp.’s holdings, making the stock its 10th largest holding. EFG Asset Management North America Corp.’s holdings in Intuitive Surgical were worth $7,309,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently made changes to their positions in ISRG. Chilton Capital Management LLC boosted its position in shares of Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 43 shares in the last quarter. Princeton Global Asset Management LLC acquired a new stake in shares of Intuitive Surgical during the 2nd quarter worth approximately $30,000. TD Capital Management LLC boosted its position in shares of Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 45 shares in the last quarter. 1248 Management LLC acquired a new stake in shares of Intuitive Surgical during the 1st quarter worth approximately $30,000. Finally, Bank of Jackson Hole Trust boosted its position in shares of Intuitive Surgical by 70.5% during the 1st quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock worth $37,000 after acquiring an additional 31 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG stock opened at $538.82 on Wednesday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The company has a market capitalization of $193.15 billion, a P/E ratio of 71.27, a price-to-earnings-growth ratio of 4.94 and a beta of 1.61. The business has a 50-day simple moving average of $467.13 and a two-hundred day simple moving average of $499.56.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same period in the previous year, the company earned $1.84 earnings per share. The firm’s revenue for the quarter was up 22.9% compared to the same quarter last year. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Ratings Changes

ISRG has been the subject of several research reports. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Raymond James Financial set a $603.00 price target on shares of Intuitive Surgical and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Sunday, October 26th. Piper Sandler raised their price target on shares of Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Finally, Robert W. Baird set a $655.00 price target on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $608.92.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 336 shares of the business’s stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the transaction, the director directly owned 1,074 shares in the company, valued at $504,898.14. The trade was a 23.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the transaction, the insider owned 19,827 shares in the company, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 96,011 shares of company stock valued at $50,309,042 in the last quarter. 0.70% of the stock is owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.